{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:05:06Z","timestamp":1793012706994,"version":"4.5.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Depression and anxiety persist in cancer patients, creating an additional burden during treatment and making it more challenging in terms of management and control. Studies on the prevalence of depression and anxiety among cancer patients in the Middle East are limited and include many limitations such as their small sample sizes and restriction to a specific type of cancer in specific clinical settings. This study aimed to describe the prevalence and risk factors of depression and anxiety among cancer patients in the inpatient and outpatient settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A total of 1,011 patients (399 inpatients and 612 outpatients) formed the study sample. Patients\u2019 psychological status was assessed using the Hospital Anxiety and Depression Scale (HADS), the Patient Health Questionnaire (PHQ-9), and the Generalized Anxiety Disorder 7-item (GAD-7) scale. The prevalence rate of depressive and anxious symptomatology was estimated by dividing the number of patients who exceeded the borderline score: 10 or more for each subscale of the HADS scale, 15 or more for the GAD-7 scale, and 15 or more in the PHQ-9 by the total number of the patients. Risk factors were identified using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of depressive and anxious symptomatology among all patients was 23.4% and 19.1\u201319.9%, respectively. Depressive symptomatology was more prevalent across patients who were hospitalized (37.1%) compared with patients in the outpatient setting (14.5%) (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Similarly, anxious symptomatology was more prevalent in the inpatient setting (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). In the inpatient setting, depressive symptomatology was more prevalent among patients with bladder cancer, while severe anxious symptomatology was more prevalent across patients with lung cancer. In the outpatient setting, depressive and anxious symptomatology was more prevalent among breast and prostate cancer patients, respectively. Despite that, around 42.7% and 24.8% of the patients, respectively, reported that they feel anxious and depressed, and only 15.5% of them were using medications to manage their conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study findings demonstrated a higher prevalence of depressive and anxious symptomatology in the inpatient setting and advanced disease stages. In addition, the underutilization of antidepressant therapy was observed. There is a need to consider mental disorders as part of the treatment protocol for cancer patients. Enhanced clinical monitoring and treatment of depression and anxiety of cancer patients are required.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyg.2021.585534","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T06:49:58Z","timestamp":1618469398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":216,"title":["Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Abdallah Y.","family":"Naser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas Nawfal","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alwafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Zmaily","family":"Dahmash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad S.","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.hemonc.2015.02.001","article-title":"Cancer care in Jordan.","volume":"8","author":"Abdel-Razeq","year":"2015","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/pon.4386","article-title":"Depression and religiosity and their correlates in Lebanese breast cancer patients.","volume":"27","author":"Abou Kassm","year":"2018","journal-title":"Psychooncology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2019030","article-title":"Meta-analysis of the prevalence of depression among breast cancer survivors in Iran: an urgent need for community supportive care programs.","volume":"41","author":"Ahmadi Gharaei","year":"2019","journal-title":"Epidemiol. Health"},{"key":"B4","first-page":"62","article-title":"Antidepressants in patients with advanced cancer: when they\u2019re warranted and how to choose therapy.","volume":"33","author":"Ahmed","year":"2019","journal-title":"Oncology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/pon.3706","article-title":"Depression in patients with colorectal cancer in Saudi Arabia.","volume":"24","author":"Al Ahwal","year":"2014","journal-title":"Psychooncology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.9740\/mhc.n194575","article-title":"Treatment of depressive symptoms in patients with cancer.","volume":"4","author":"Baltenberger","year":"2014","journal-title":"Mental Health Clin."},{"key":"B7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review.","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1037\/a0022566","article-title":"Cancer patients with major depressive disorder: testing a biobehavioral\/cognitive behavior intervention.","volume":"79","author":"Brothers","year":"2011","journal-title":"J. Consult. Clin. Psychol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/0284186x.2016.1266090","article-title":"Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review.","volume":"56","author":"Caruso","year":"2017","journal-title":"Acta Oncol."},{"key":"B10","year":"2019","journal-title":"Global Health- Jordan."},{"key":"B11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(01)00456-9","article-title":"Depression in cancer patients.","volume":"2","author":"Chochinov","year":"2001","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00520-008-0529-7","article-title":"Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting.","volume":"17","author":"Delgado-Guay","year":"2009","journal-title":"Support Care Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/pon.4681","article-title":"The generalized anxiety disorder screener (GAD-7) and the anxiety module of the hospital and depression scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.","volume":"27","author":"Esser","year":"2018","journal-title":"Psychooncology"},{"key":"B14","article-title":"Depression treatment patterns among elderly with cancer.","volume":"2012","author":"Findley","year":"2012","journal-title":"Depress Res. Treat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00127-005-0992-0","article-title":"Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.","volume":"41","author":"H\u00e4rter","year":"2006","journal-title":"Soc Psychiatry Psychiatr. Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1002\/cncr.30846","article-title":"The hospital anxiety and depression scale (HADS) and the 9-item patient health questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.","volume":"123","author":"Hartung","year":"2017","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0728-6","article-title":"Assessment of depression severity with the PHQ-9 in cancer patients and in the general population.","volume":"16","author":"Hinz","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.2217\/fon-2017-0306","article-title":"Steroid-induced mental disorders in cancer patients: a systematic review.","volume":"13","author":"Ismail","year":"2017","journal-title":"Future Oncol."},{"key":"B19","article-title":"Psychological interventions for women with non-metastatic breast cancer.","volume":"28","author":"Jassim","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0167-8140(93)90073-h","article-title":"Psychological distress in cancer patients with advanced disease.","volume":"27","author":"Kaasa","year":"1993","journal-title":"Radiother. Oncol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5975","article-title":"Use and appreciation of a tailored self-management ehealth intervention for early cancer survivors: process evaluation of a randomized controlled trial.","volume":"18","author":"Kanera","year":"2016","journal-title":"J. Med. Internet Res."},{"key":"B22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2190\/M1F5-F40P-C4KD-YPA3","article-title":"A brief depression scale for use in the medically ill.","volume":"22","author":"Koenig","year":"1992","journal-title":"Int. J. Psychiatry Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pon.3409","article-title":"Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.","volume":"23","author":"Krebber","year":"2014","journal-title":"Psychooncology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1200\/jco.2015.65.7874","article-title":"Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: a randomized controlled trial.","volume":"34","author":"Lengacher","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s0033291721000131","article-title":"Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis.","volume":"365","author":"Levis","year":"2019","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1200\/jco.2011.39.7372","article-title":"Evidence-based treatment of depression in patients with cancer.","volume":"30","author":"Li","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B28","first-page":"1","author":"Lwanga","year":"1991","journal-title":"Sample size Determination in Health Studies: A Practical Manual."},{"key":"B29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","article-title":"Prevalence of depression in patients with cancer.","author":"Massie","year":"2004","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jpainsymman.2018.08.004","article-title":"Depression and health care utilization at end of life among older adults with advanced non-small-cell lung cancer.","volume":"56","author":"McDermott","year":"2018","journal-title":"J. Pain Symptom Manage."},{"key":"B31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s1470-2045(11)70002-x","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interviewbased studies.","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pon.3372","article-title":"Comorbidity of common mental disorders with cancer and their treatment gap: findings from the world mental health surveys.","volume":"23","author":"Nakash","year":"2014","journal-title":"Psychooncology"},{"key":"B33","doi-asserted-by":"crossref","first-page":"664.e1","DOI":"10.1016\/j.urolonc.2017.07.016","article-title":"Association of androgen deprivation therapy and depression in the treatment of prostate cancer: a systematic review and meta-analysis.","volume":"35","author":"Nead","year":"2017","journal-title":"Urologic Oncol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6181-4","article-title":"Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority.","volume":"19","author":"Niedzwiedz","year":"2019","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/jncimonographs\/lgh026","article-title":"Evidence report on the occurrence, assessment, and treatment of depression in cancer patients.","author":"Pirl","year":"2004","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"B36","article-title":"Depression and anxiety in patients with cancer.","volume":"361","author":"Pitman","year":"2018","journal-title":"BMJ"},{"key":"B37","first-page":"232","article-title":"Chemotherapy-induced nausea and vomiting: optimizing prevention and management.","volume":"5","author":"Rao","year":"2012","journal-title":"Am. Health Drug Benefits"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpainsymman.2016.08.005","article-title":"Mindfulness-based stress reduction in post-treatment breast cancer patients: immediate and sustained effects across multiple symptom clusters.","volume":"53","author":"Reich","year":"2017","journal-title":"J. Pain Symptom. Manage."},{"key":"B39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.psychres.2016.03.030","article-title":"Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.","volume":"239","author":"Sawaya","year":"2016","journal-title":"Psychiatry Res."},{"key":"B40","first-page":"1","article-title":"UMHS depression guideline.","author":"Schwenk","year":"2011","journal-title":"Guidelines for Clinical Care Ambulatory"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: pathogenesis, implications and treatment (Review).","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/s0140-6736(89)91551-1","article-title":"Effect of psychosocial treatment on survival of patients with metastatic breast cancer.","volume":"2","author":"Spiegel","year":"1989","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/cncr.22890","article-title":"Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.","volume":"110","author":"Spiegel","year":"2007","journal-title":"Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/sja.sja_43_17","article-title":"Development and validation of Arabic version of the hospital anxiety and depression scale.","volume":"11","author":"Terkawi","year":"2017","journal-title":"Saudi J. Anaesth."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/jco.2013.54.9386","article-title":"BREATH: web-based self-management for psychological adjustment after primary breast cancer\u2013results of a multicenter randomized controlled trial.","volume":"33","author":"van den Berg","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/bjc.2011.503","article-title":"Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer.","volume":"105","author":"Vodermaier","year":"2011","journal-title":"Br. J. Cancer"},{"key":"B48","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annonc\/mds575","article-title":"Prevalence of depression in adults with cancer: a systematic review.","volume":"24","author":"Walker","year":"2013","journal-title":"Ann. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s2215-0366(14)70313-x","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.","volume":"1","author":"Walker","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/070674370404900208","article-title":"Prevalence and incidence studies of mood disorders: a systematic review of the literature.","volume":"49","author":"Waraich","year":"2004","journal-title":"Can. J. Psychiatry."},{"key":"B51","year":"2018","journal-title":"International Agency for Research on Cancer, Globocan 2018- Jordan."},{"key":"B52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2021.585534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T06:50:12Z","timestamp":1618469412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2021.585534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":52,"alternative-id":["10.3389\/fpsyg.2021.585534"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2021.585534","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"article-number":"585534"}}